检索

标题
作者
Knowledge of senior students in the definition, classification, and approaches to the treatment of arterial hypertension. Final results of the PHYSTARH project
Bontsevich R., Vovk Y., Gavrilova A., Batishcheva G., Goncharova N., Elizarova I., Ketova G., Barysheva V., Bikkinina G., Myronenko O.
The efficiency of two-level electrovectorcardiographic diagnostics of left ventricular hypertrophy in the medical examination of urban and rural population
Riabykina G., Vishniakova N., Fedorova V.
Blood pressure variability, endothelial dysfunction, and C-reactive protein levels in arterial hypertension in combination with coronary artery disease
Musikhina N., Petelina T., Gapon L., Kostousova A.
Management of patients with arterial hypertension and atrial fibrillation
Chazova I., Golitsyn S., Zhernakova J., Zheleznova E., Kropacheva E., Mironov N., Kostiukevich M., Laiovich L., Utsumueva M., Iuricheva I., Litvin A., Elfimova E., Rogoza A., Panchenko E.
Predictors of cardiovascular complications in patients with arterial hypertension and comorbid pathology
Murkamilov I., Fomin V., Yusupov F., Sabirov I.
Drug-induced arterial hypertension
Ostroumova O., Kulikova M.
Demographic and clinical differences between idiopathic and scleroderma-related pulmonary arterial hypertension: Russian National Registry analysis
Yudkina N., Valeeva E., Taran I., Nikolaeva E., Paramonov V., Kurmukov I., Valieva Z., Arkhipova O., Martynyuk T., Volkov A., Nasonov E., Chazova I.
The validation of the questionnaire for the early detection of pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension
Valieva Z., Glukhova S., Martyniuk T., Chazova I.
The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension
Valieva Z., Valeeva E., Glukhova S., Martynyuk T., Chazova I.
Clinical features and course of arterial hypertension in patients with its various forms
Denisova A., Esaulova T., Solntseva T., Sivakova O., Chazova I.
Etiopathogenesis, diagnosis, and approaches to the treatment of arterial hypertension: an assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project
Bontsevich R., Vovk Y., Gavrilova A., Kirichenko A., Ebzeeva E., Kosmacheva E., Kompaniets O., Prozorova G., Nevzorova V., Martynenko I., Barysheva V., Ketova G., Maksimov M., Osipova O.
Possibilities of treatment of patients with resistant arterial hypertension
Shugushev Z., Maximkin D., Ryumina A.
Clinical practice guidelines on the diagnosis and treatment of patients with arterial hypertension and chronic obstructive pulmonary disease
Chazova I., Nevzorova V., Ambatiello L., Brodskaia T., Oshchepkova E., Belevskii A., Zhernakova J., Aisanov Z., Ovcharenko S., Chuchalin A.
Drug therapy of arterial hypertension: assessment of the physicians’ basic knowledge. Final results of the PHYSTARH project
Bontsevich R., Vovk Y., Gavrilova A., Kirichenko A., Krotkova I., Kosmacheva E., Kompaniets O., Prozorova G., Nevzorova V., Martynenko I., Ketova G., Barysheva V., Maksimov M., Osipova O.
Uncontrolled arterial hypertension: main causes, features of pathogenesis and approaches to treatment
Denisova A., Solntseva T., Sivakova O., Chazova I.
Uncontrolled arterial hypertension in patients with breast cancer and the risk of developing cardiotoxicity with anthracycline-containing chemotherapy
Oshchepkova E., Avalyan A., Rogoza A., Gorieva S., Saidova M., Chazova I.
The possibility of a new receptor blocker to angiotensin in improving control of hypertension. Non-intervention international multicenter observational prospective study of the use azilsartan medoxomil in patients with arterial hypertension and overweight or obesity in the Russian Federation and the Republic of Kazakhstan
Zhernakova Y., Chazova I.
Features of the use of torasemide in arterial hypertension
Baryshnikova G., Chorbinskajya S.
Quality assessment of examination of patients with arterial hypertension in primary health care (according to the Russian arterial hypertension register data)
Oshchepkova E., Lazareva N., Chazova I.
Endothelin receptor antagonist bosentan role in modern strategy for patients with pulmonary arterial hypertension treatment
Arkhipova O., Martynyuk T.
Quality of life in patients with idiopathic pulmonary hypertension: the first experience of trimetazidine
Kuznetsova E., Glukhova S., Martynyuk T., Nakonechnikov S., Chazova I.
Workplace hypertension": focus on emotional and personality traits in patients
Ostroumova O., Pervichko E., Zinchenko Y.
Features of cutaneous microcirculatory blood flow in patients with pulmonary hypertension of different etiology
Dolgova E., Fedorovich A., Martynyuk T., Rogoza A., Chazova I.
Myocardial ischemia in patients with pulmonary arterial hypertension
Arkhipova O., Martyniuk T., Valeeva E., Ryabykina G., Samoylenko L., Sergienko V., Chazova I.
Modernization of hypertension treatment in the Yaroslavl region: interim results of the yearly comprehensive program for modernization of the regional healthcare system
Mozheyko M., Eregin S., Vigdorchik A., Klimovskaia I., Riahi F., Hughes D.
Evaluation of effectiveness and safety of the first Russian-manufactured generic bosentan use in patients with pulmonary arterial hypertension
Arkhipova O., Gratsianskaya S., Martynyuk T.
Specificity of the effect of double fractures of the rhythmogram on the daily variability of the sinus rhythm in patients with pulmonary and arterial hypertension
Sobolev A., Ryabykina G., Kozhemyakina E.
Clinical Manual for Diagnosis, Prevention and Treatment of Cardiovascular Complications of Cancer Therapy. Parts II-V
Chazova I., Tyulyandin S., Vitsenia M., Poltavskaya M., Gilyarov M., Martynyuk T., Ovchinnikov A., Panchenko E., Fedotkina Y., Stenina M., Trophimova O., Ageev F.
Clinical, functional and hemodynamic profile of patients with Eisenmenger syndrome in comparison with the group of idiopathic pulmonary hypertension, features of starting specific therapy choice
Gratsianskaya S., Valieva Z., Zorin A., Martynyuk T.
Chronic myocardial damage in idiopathic pulmonary arterial hypertension: a clinical case
Bykov A., Arkhipov M., Klimusheva N., Iofin A., Krokhalev V.
Implementation of the organoprotective properties of fixed combinations of valsartan, amlodipine and hydrochlorothiazide (Vamloset® and Co-Vamloset) in patients with grade 2 and 3 hypertension in the Russian clinical study VICTORY II
Chazova I., Martynyuk T., Rodnenkov O., Gorieva S., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Khaisheva L., Kameneva T.
Vascular stiffness in patients with arterial hypertension: possible antihypertensive therapy
Ostroumova O., Kochetkov A., Lopukhina M.
Effect of renal denervation on the arterial stiffness and central hemodynamics in patients with resistant hypertension
Shchelkova G., Zairova A., Danilov N., Rogoza A., Chazova I.
Organoprotective properties of therapy by fixed combination of perindoprile and amlodipine in patients with arterial hypertension and diabetes mellitus type 2
Statsenko M., Turkina S., Titarenko M.
The effect of combined antihypertensive therapy on arterial wall rigidity in male patients with hypertension, obesity and obstructive sleep apnea
Elfimova E., Zairova A., Andrievskaya M., Bogieva R., Rogoza A., Litvin A.
Features of cerebral autoregulation and reactivity in patients with arterial hypertension in older age groups with orthostatic hypotensive reactions
Atyunina I., Oshchepkova E., Rogoza A.
Radiofrequency denervation of the renal arteries in patients with resistant arterial hypertension: 3 years of observation experience
Savelyeva N., Zherzhova A., Mikova E., Gapon L., Kolunin G., Krinochkin D.
The nature of the course of arterial hypertension in low-renin hyperaldosteronism
Chikhladze N.
The condition of parameters of memory, attention and thinking at men of young age officers under the contractwith arterial hypertension.
Davidovich I., Afonaskov O., Staroverova Y.
Amlodipine: its ability to reduce the risk of complications of arterial hypertension
Runikhina N., Tkacheva O.
Prevention of cardiovascular events at patients with arterial hypertension at treatmentangiotensin-converting enzyme inhibitor.
Kislyak O., Postnikova S.
The place of b-blocker and diuretic in the Russian guidelines of arterial hypertension 2008
Chazova I., Ratova L., Chazova I., Ratova L.
Radiofrequency renal denervation with different device for treatment in patient with uncontrolled hypertension
Agaeva R., Danilov N., Shelkova G., Sagaydak O., Grigin V., Matchin U., Chazova I.
The new angiotensin II receptor blocker Edarbi® as part of the pathogenetic treatment of arterial hypertension in patients with metabolic disorders
Chazova I., Zhernakova Y., Blinova N., Rogoza A.
Fixed combination of highly selective β-adrenoblocker bisoprolol and calcium antagonist amlodipine (Concor® AM) for arterial hypertension treatment in metabolic disorder patients
Zhernakova Y., Martyniuk T., Arkhipova O., Azimova M., Rogoza A., Chazova I.
Control of cardiovascular risk in patients with diabetes
Zhernakova Y., Chazova I.
Chronotherapy’s opportunities of a fixed combination of perindopril 10 mg/indapamide 2.5 mg in patients with a lack of night reduction in blood pressure
Aksenova A., Elfimova E., Litvin A., Chazova I.
The major arteries and skin microcirculatory vessels status and antihypertensive therapy effect on them in hypertensive patients with high and very high cardiovascular risk
Mordvinova E., Oshchepkova E., Fedorovich A., Zairova A., Pogorelova O., Tripoten M., Rogoza A.
From the choice of antihypertensive drug to the choice of fixed combinations of antihypertensive drugs: a paradigm shift
Ostroumova O., Bondarets O., Kopchenov I., Guseva T.
Dependence of the efficiency of the initial state of fosinopril structure common carotid arteries, intravascular blood flow and central hemodynamics at patients with arterial hypertension
Melnikova L., Bartosh L., Grechishkina O.
The efficacy offixed combination of bisoprolol and amlodipine in patients with arterial hypertension, ischemic heart disease and metabolic syndrome
Skibickiy V., Fendrikova A., Skibickiy A., Syrotenko D.
Efficacy and safety of different regimens of fixed combinationof perindopril 10 mg/indapamide 2.5 mg in patients with arterial hypertension
Elfimova E., Aksenova A., Litvin A., Chazova I.
The role of the vegetative part of sympathetic nervous system in development of cardiovascular complications in patients with arterial hypertension: pharmacological aspects
Gilyarevsky S.
Beta-adrenergic blocking agent in cardiovascular disease: focus on metoprolol
Baryshnikov G., Stepanova I., Kudryavtseva N.
Modern opportunities of monotherapy in patients with arterial hypertension associated with comorbid disorders
Gorokhovskaya G., Yun V.
Education and self-education of the patients is an important step towards increasing patients acceptance of therapy
Chazova I., Ageev F., Fofanova T., Chikhladze N., Kuznetsova M., Smirnova M., Ostrogorskaya V., Geraschenko Y.
Place of arterial hypertension in brain lesion development - from minor cognitive disorders to dementia
Shishkova V.
Modern possibilities of hypertension drug therapy. Candesartan and its place in the therapy
Barbarash O., Kashtalap V.
Use of diuretics in hypertensive patients with metabolic disturbances
Zhernakova Y., Chazova I.
Real and potential benefits of third-generation calcium antagonists
Kirichenko A.
Diurnal blood pressure variability as a risk factor for complications of arterial hypertension
Ostroumova O., Reznikova K.
Comparative characteristics of indicators of peripheral arterial and central aortic pressure, remodeling of the left ventricular myocardium in salt-sensitive and salt-resistant patients with arterial hypertension
Skibitskiy V., Vasil'ev V., Fendrikova A., Pyatakov S.
Expert consensus. Effect of antihypertensive therapy on cognitive functions
Ostroumova O., Parfenov V., Ostroumova T., Yakhno N., Chazova I., Bogolepova A., Galyavich A., Geraskina L., Emelin A., Zakharov V., Kislyak O., Kulesh A., Levin O., Podzolkov V., Privalova E., Shikh E.
First results of Russian multicenter prospective clinical study VICTORY II: Vamloset® and Co-Vamloset effectiveness and safety in patients with stage 2 and 3 arterial hypertension
Chazova I., Martynyuk T., Rodnenkov V., Gorieva B., Rogoza A., Arkhipov M., Grinshtein Y., Ostroumova O., Galiavich A., Rotar’ O., Haisheva L., Kameneva T.
Target blood pressure levels in patients with arterial hypertension and frailty
Ostroumova O., Cherniaeva M., Morozov A.
Direct renin inhibitors aliskiren - possibilities correction cardiorenal syndrome
Chazova I., Fomin V.
Possible combinations of antihypertensive drugs at treatment of arterial hypertension at patientswith metabolic syndrome
Mychka V., Chazova I., Mychka V., Chazova I.
The role of angiotensin receptor antagonists in treatment of arterial hypertension: focus on losartan
Baryshnikova G., Baryshnikova G.
Combined antihypertensive therapy in the light of modern recommendations: strategy of one tablet
Morozova T.
The relationship between the antihypertensive effect of b-adrenergic blockers and the initial daily variability of sinus rhythm
Sobolev A., Talabanov P., Ryabykina G., Kozhemyakina E.
Guidelines for diagnostics and treatment of hypertension 2018 - European experts’opinion [Guidelines]
Chazova I., Zhernakova Y.
Pulmonary hypertension: reasonable selection of specific therapy
Karoli N., Sazhnova S., Rebrov A.
Markers of early cardiotoxicity in patients with breast cancer undergoing chemotherapy depending on blood pressure level
Avalyan A., Kirillova M., Shitov V., Oshchepkova Y., Saidova M., Stenina M., Chazova I.
The effect of combined therapy on the properties of the vessel wall in patients at high risk of cardiovascular complications
Blankova Z., Aslanyan N.
The effect of antihypertensive therapy and CPAP therapy on inflammatory and endothelial dysfunction markers levels in patients with severe obstructive sleep apnea syndrome in association with arterial hypertension
Elfimova E., Rvacheva A., Tripoten M., Pogorelova O., Balakhonova T., Zykov K., Litvin A.
A fixed combination of amlodipine and losartan: effectiveness and safety in abnormal weather conditions in patients with arterial hypertension
Ageev F., Smirnova M., Fofanova T., Blankova Z., Vitsenya M., Tsybulskaya T., Neverova E., Samsonova N.
Diuretics in combination antihypertensive therapy: focus on forecast
Chazova I., Martyniuk T.
Treatment with perindopril in patients with arterial hypertension: improving compliance
Anikin G., Minina E., Andreevskaya E.
The meaning of hypertensive therapy choice in the correction of cerebral affection: from mild cognitive impairment to dementia
Shishkova V.
The role of beta-blockers in the treatment of arterial hypertension: what do we know today
Zhernakova Y., Chazova I.
The application of torasemide in patients with arterial hypertension: evidence-based and practical approaches
Gilyarevsky S., Kuzmina I., Golshmid M.
The treatment options of the new angiotensin II receptor blocker - azilsartan medoxomil in the therapy of hypertension in patients with metabolic disorders
Zhernakov Y., Chazova I.
The problem of determining the efficiency of treatmentin the era of evidence-based medicine: international and domestic experience
Gilyarevsky S.
The results of the open observational, international, multicenter, prospective program to assess the efficacy, safety and tolerability of the first direct renin inhibitor RasilezR (aliskiren) in patients with arterial hypertension in ‘real-life’ clinical practice settings (DRIve)
Chazova I.
Risk of target organ damage in patients with arterial hypertension and various numbers of metabolic syndrome components
Zhernakova Y., Sharipova G., Chazova I.
Rational pharmacotherapy of hypertension. Urapidil potential
Morozova T., Andruschishina T., Shmarova D.
Effect of angiotensin II receptor antagonists on left ventricular hypertrophy, vascular elasticity, and lipid and carbohydrate metabolic parameters in metabolic syndrome
Nedogoda S., Salasyuk A., Chalyabi T., Barykina I., Pocheptsov D., Ledyaeva A., Tsoma V., Chumachek E.
Iloprost for acute tests in patients with pulmonary arterial hypertension
Belyatko E., Danilov N., Matchin Y., Martynyuk T., Chazova I.
HYVET: landmark trial voted 2008 Trialof the Year by the ImpACT/Society for Clinical Trials and the American Heart Association
Prevalence of risk factors for arterial hypertension among draft age youth
Uvarovskaia B., Mel’nik M., Kniazeva S.
Combined antihypertensive and psychocorrective therapy in patients with arterial hypertension and anxiety-depressive disorders: are there any advantages?
Skibitsky V., Ginter J., Fendrikova A., Sirotenko D.
Renal artery denervation in patients with resistant arterial hypertension: clinical and organ-protective effect
Gapon L., Mikova E., Krinochkin D., Savelyeva N., Zherzhova A., Aleksandrovich E.
Clinical guidelines on arterial hypertension diagnosis, treatment and prevention in children and adolescents
Aleksandrov A., Kisliak O., Leontyeva I.
Risk factors for falls in patients with arterial hypertension
Khovasova N., Naumov A., Tkacheva O., Moroz V.
The improved form perindopril in treatment of arterial hypertension in various clinical situations (PREMIA)
Mychka V., Zhernakova Y., Chazova I.
The use of angiotensin receptor blocker losartan in the combinational therapy of arterial hypertension
Zagidullin N., Zagidullin S.
Efficacy of the fixed combination β-blocker and calcium antagonist Logimax at women with an essential hypertensionin different age groups
Ostroumova O., Zhukova O., Golovina O., Srednyakov A., Otdelenov A.
The role of b-blockers in the new revision of the 2018 European guidelines for the diagnosis and treatment of arterial hypertension in the patients with comorbidities
Ostroumova O., Kochetkov A.
Stroke prevention in patients with atrial fibrillation and comorbidities
Ostroumova O., Voevodina N., Guseva T., Pavleeva E., Piksina G., Goloborodova I.
The problem of broncho-obstructive syndrome early detection in cardiological patients. Review of specialized respiratory questionnaires and their use in patients with comorbid cardiovascular and broncho-obstructive pathologies
Klimova A., Ambatello L., Smolyakova E., Nistor S., Zykov K., Chazova I.
1 - 100 的 255 信息 1 2 3 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语

##common.cookie##